查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1572032

葡萄糖生物感测器的全球市场

Glucose Biosensors
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 93 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计2030年全球葡萄糖生物感测器市场将达到41亿美元

葡萄糖生物感测器的全球市场预计到 2023 年将达到 36 亿美元，预计到 2030 年将达到 41 亿美元，在 2023-2030 年分析期间复合年增长率为 2.1%。医院最终用途是本报告分析的细分市场之一，预计复合年增长率为 1.8%，到分析期结束时将达到 15 亿美元。在分析期间，居家照护诊断最终用途行业的复合年增长率预计为 2.5%。

美国市场预估达9.603亿美元，中国预计复合年增长率为3.1%

预计 2023 年美国葡萄糖生物感测器市场规模将达到 9.603 亿美元。中国作为世界第二大经济体，预计2030年市场规模将达到7.656亿美元，2023-2030年分析期间复合年增长率为3.1%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 1.5% 和 1.9%。在欧洲，德国的复合年增长率预计为 1.8%。

全球葡萄糖生物感测器市场—主要趋势和驱动因素总结

葡萄糖生物感测器如何增强糖尿病管理？

血糖生物感测器是糖尿病管理的重要工具，为患者提供即时血糖值监测。这些感测器对于血糖仪和连续血糖监测 (CGM) 设备至关重要，它们使用酶促反应和电化学检测方法来测量血液中的血糖水平。具有 24 小时追踪功能的连续血糖监测系统可以为患者提供更多资料，以做出有关胰岛素剂量、饮食和活动改善的明智决策，从而显着改善糖尿病管理。随着全球糖尿病盛行率的不断上升，对准确、可靠和用户友好的葡萄糖生物感测器的需求不断增加，以帮助患者更好地控制疾病。

葡萄糖生物感测器的主要细分领域和应用有哪些？

葡萄糖生物感测器市场按电化学生物感测器、光学生物感测器和酵素生物感测器等技术细分。电化学生物感测器透过酵素反应产生的电讯号测量葡萄糖浓度，由于其准确性、经济性以及在 CGM 设备和血糖仪中的广泛使用，在市场上占据主导地位。使用基于光的检测方法的光学生物感测器也越来越受欢迎，特别是对于非侵入性监测系统。从应用来看，葡萄糖生物感测器主要应用于自我血糖监测（SMBG）系统和连续血糖监测设备。主要的最终用户是医院、诊所和居家医疗。北美地区因其高患病率和发达的医疗基础设施而引领市场，而亚太地区则由于糖尿病患病率上升和医疗保健机会的改善而经历快速增长。

科技进步如何影响葡萄糖生物感测器？

技术创新正在推动葡萄糖生物感测器的改进，特别是在非侵入性监测、感测器准确性以及与数位健康平台整合等领域。透过穿戴式感测器提供即时资料的连续血糖监测 (CGM) 系统减少了频繁的指尖采血测试的需要，彻底改变了糖尿病管理。感测器小型化、生物相容性材料和无线连接的进步使这些设备对患者来说更加舒适和方便。透过将葡萄糖生物感测器与行动应用程式和云端平台集成，患者和医疗保健提供者可以追踪趋势并做出资料驱动的决策。此外，对光学和经皮感测器等非侵入性血糖监测方法的研究为糖尿病治疗的未来带来了希望。

推动葡萄糖生物感测器市场成长的因素有哪些？

葡萄糖生物感测器市场的成长受到多种因素的推动，例如全球糖尿病盛行率的上升以及对连续即时血糖监测解决方案的需求不断增加。生物感测器技术的进步，包括感测器精度的提高、小型化和非侵入性监测技术，正在改善患者体验并扩大葡萄糖生物感测器在临床和家庭环境中的使用。旨在改善糖尿病管理的政府措施和医疗保健政策进一步推动了先进血糖监测设备的采用。葡萄糖生物感测器和数位健康平台的日益集成，以改善患者和医疗保健提供者的沟通和资料分析，也推动了市场成长。

调查企业范例（共42例）

  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • AgaMatrix Inc.
  • Bayer
  • Biacore
  • BioSense Medical Devices, LLC
  • Biosensors International Pte. Ltd.
  • LifeScan, Inc.
  • LifeSensors, Inc.
  • Medtronic, Inc.
  • Nova Biomedical
  • Pharmaco-Kinesis Corporation
  • Pinnacle Medical Solutions, Inc.
  • Roche Diagnostics
  • Sanofi SA

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP21894

Global Glucose Biosensors Market to Reach US$4.1 Billion by 2030

The global market for Glucose Biosensors estimated at US$3.6 Billion in the year 2023, is expected to reach US$4.1 Billion by 2030, growing at a CAGR of 2.1% over the analysis period 2023-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 1.8% CAGR and reach US$1.5 Billion by the end of the analysis period. Growth in the Homecare Diagnostics End-Use segment is estimated at 2.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$960.3 Million While China is Forecast to Grow at 3.1% CAGR

The Glucose Biosensors market in the U.S. is estimated at US$960.3 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$765.6 Million by the year 2030 trailing a CAGR of 3.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.5% and 1.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.8% CAGR.

Global Glucose Biosensors Market - Key Trends and Drivers Summarized

How Are Glucose Biosensors Enhancing Diabetes Management?

Glucose biosensors are critical tools in the management of diabetes, providing real-time monitoring of blood glucose levels for patients. These sensors, which are integral to glucose meters and continuous glucose monitoring (CGM) devices, measure the concentration of glucose in the blood using enzymatic reactions and electrochemical detection methods. Continuous glucose monitoring systems, which offer around-the-clock tracking, have significantly improved diabetes management by providing patients with more data to make informed decisions about their insulin dosing, diet, and activity. With the rising prevalence of diabetes worldwide, the demand for accurate, reliable, and user-friendly glucose biosensors is on the rise, helping patients maintain better control over their condition.

What Are the Key Segments and Applications of Glucose Biosensors?

The glucose biosensors market is segmented by technology, including electrochemical, optical, and enzymatic biosensors. Electrochemical biosensors, which measure glucose concentration through electrical signals generated by enzymatic reactions, dominate the market due to their accuracy, affordability, and widespread use in CGM devices and glucose meters. Optical biosensors, which use light-based detection methods, are also gaining traction, particularly for non-invasive monitoring systems. In terms of application, glucose biosensors are primarily used in self-monitoring blood glucose (SMBG) systems and continuous glucose monitoring devices. Hospitals, clinics, and home healthcare settings represent the primary end-users. North America leads the market due to the high prevalence of diabetes and advanced healthcare infrastructure, while Asia-Pacific is experiencing rapid growth as diabetes rates rise and access to healthcare improves.

How Are Technological Advancements Impacting Glucose Biosensors?

Technological innovations are driving improvements in glucose biosensors, particularly in the areas of non-invasive monitoring, sensor accuracy, and integration with digital health platforms. Continuous glucose monitoring (CGM) systems, which provide real-time data through wearable sensors, have transformed diabetes management by reducing the need for frequent finger-prick tests. Advances in sensor miniaturization, biocompatible materials, and wireless connectivity are making these devices more comfortable and convenient for patients. The integration of glucose biosensors with mobile apps and cloud platforms is enabling patients and healthcare providers to track trends and make data-driven decisions. Additionally, research into non-invasive glucose monitoring methods, such as optical and transdermal sensors, holds promise for the future of diabetes care.

What Factors Are Driving the Growth in the Glucose Biosensors Market?

The growth in the glucose biosensors market is driven by several factors, including the rising global prevalence of diabetes and the increasing demand for continuous, real-time glucose monitoring solutions. Advances in biosensor technology, including improvements in sensor accuracy, miniaturization, and non-invasive monitoring techniques, are enhancing the patient experience and expanding the use of glucose biosensors in both clinical and home settings. Government initiatives and healthcare policies aimed at improving diabetes management are further supporting the adoption of advanced glucose monitoring devices. The growing integration of glucose biosensors with digital health platforms, enabling better patient-provider communication and data analysis, is also fueling market growth.

Select Competitors (Total 42 Featured) -

  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • AgaMatrix Inc.
  • Bayer
  • Biacore
  • BioSense Medical Devices, LLC
  • Biosensors International Pte. Ltd.
  • LifeScan, Inc.
  • LifeSensors, Inc.
  • Medtronic, Inc.
  • Nova Biomedical
  • Pharmaco-Kinesis Corporation
  • Pinnacle Medical Solutions, Inc.
  • Roche Diagnostics
  • Sanofi S.A.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Glucose Biosensors - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Diabetes Globally Propels Demand for Glucose Biosensors
    • Technological Innovations in Continuous Glucose Monitoring (CGM) Devices Strengthen Market Growth
    • Increasing Adoption of Wearable Glucose Biosensors Drives Market Expansion
    • Growing Focus on Non-Invasive Glucose Monitoring Technologies Creates Opportunities
    • Rising Demand for Portable and Convenient Glucose Monitoring Devices Expands Addressable Market
    • Advancements in Sensor Accuracy and Reliability Propel Adoption of Glucose Biosensors
    • Increasing Integration of Biosensors with Mobile Apps and Cloud Platforms Boosts Demand
    • Rising Adoption of Glucose Biosensors in Personalized Medicine Strengthens Business Case
    • Growing Preference for Continuous Glucose Monitoring over Traditional Testing Methods Drives Growth
    • Technological Developments in Miniaturized and Implantable Biosensors Spur Innovation
    • Rising Demand for Real-Time Monitoring Solutions in Healthcare Expands Market for Biosensors
    • Growing Healthcare Expenditure and Insurance Coverage for Diabetes Management Support Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Glucose Biosensors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Glucose Biosensors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Glucose Biosensors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Homecare Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Homecare Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Homecare Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Glucose Biosensors Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: USA 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: Canada 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: Japan 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: China 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Glucose Biosensors by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Glucose Biosensors by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Glucose Biosensors by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: France 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Germany 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Italy 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: UK 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Spain 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Russia 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Rest of Europe 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Glucose Biosensors by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Glucose Biosensors by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Glucose Biosensors by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Asia-Pacific 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Australia 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • INDIA
    • Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 62: India Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: India 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: South Korea 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Glucose Biosensors by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Glucose Biosensors by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Latin America 16-Year Perspective for Glucose Biosensors by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Latin America 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 77: Argentina Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Argentina Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Argentina 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 80: Brazil Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Brazil Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Brazil 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 83: Mexico Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Mexico Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Mexico 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Latin America Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Latin America 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Glucose Biosensors by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Glucose Biosensors by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Middle East 16-Year Perspective for Glucose Biosensors by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Middle East 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 95: Iran Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Iran Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Iran 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 98: Israel Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Israel Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Israel 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Saudi Arabia Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Saudi Arabia 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 104: UAE Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UAE Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: UAE 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Rest of Middle East Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Rest of Middle East 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • AFRICA
    • Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 110: Africa Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Africa Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Africa 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION